Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Cells
|
January 21, 2022
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
Paola Fisicaro, Carolina Boni
Gut
|
November 20, 2021
HBV antigens quantity: duration and effect on functional cure
Antonio Bertoletti, Carolina Boni
Frontiers in Immunology
|
September 7, 2023
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers
Valeria Barili, Paola Fisicaro, Carolina Boni
Journal of Hepatology
|
January 8, 2004
Immunopathogenesis of hepatitis B
Carlo Ferrari, Gabriele Missale, Carolina Boni, et al.
Current Opinion in Virology
|
February 8, 2018
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming
Paola Fisicaro, Carolina Boni, Valeria Barili, et al.
Talanta
|
August 30, 2011
Cobalt phthalocyanine as a biomimetic catalyst in the amperometric quantification of dipyrone using FIA
Ana Carolina Boni, Ademar Wong, Rosa Amália Fireman Dutra, et al.
Virus Research
|
March 12, 2002
Comparative pathogenesis of HBV and HCV
Gabriele Missale, Amalia Penna, Carolina Boni, et al.
Journal of Hepatology
|
February 13, 2017
T cell regulation in HBV-related chronic liver disease
Carlo Ferrari, Carolina Boni, Marzia Rossi, et al.
Journal of Virology
|
November 20, 2002
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C
Simona Urbani, Carolina Boni, Gabriele Missale, et al.
Gastroenterology
|
April 6, 2012
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells
Elena Sandalova, Diletta Laccabue, Carolina Boni, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Cells
|
January 21, 2022
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
Paola Fisicaro, Carolina Boni
Gut
|
November 20, 2021
HBV antigens quantity: duration and effect on functional cure
Antonio Bertoletti, Carolina Boni
Frontiers in Immunology
|
September 7, 2023
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers
Valeria Barili, Paola Fisicaro, Carolina Boni
Journal of Hepatology
|
January 8, 2004
Immunopathogenesis of hepatitis B
Carlo Ferrari, Gabriele Missale, Carolina Boni, et al.
Current Opinion in Virology
|
February 8, 2018
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming
Paola Fisicaro, Carolina Boni, Valeria Barili, et al.
Talanta
|
August 30, 2011
Cobalt phthalocyanine as a biomimetic catalyst in the amperometric quantification of dipyrone using FIA
Ana Carolina Boni, Ademar Wong, Rosa Amália Fireman Dutra, et al.
Virus Research
|
March 12, 2002
Comparative pathogenesis of HBV and HCV
Gabriele Missale, Amalia Penna, Carolina Boni, et al.
Journal of Hepatology
|
February 13, 2017
T cell regulation in HBV-related chronic liver disease
Carlo Ferrari, Carolina Boni, Marzia Rossi, et al.
Journal of Virology
|
November 20, 2002
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C
Simona Urbani, Carolina Boni, Gabriele Missale, et al.
Gastroenterology
|
April 6, 2012
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells
Elena Sandalova, Diletta Laccabue, Carolina Boni, et al.
Page
of 6